age-related macular degeneration (AMD)

news

Novartis acquires Arctos Medical to develop gene therapy programme

22 September 2021 | By Anna Begley (European Pharmaceutical Review)

The Arctos Medical acquisition will expand Novarits’ optogenetics portfolio to bring gene therapies to patients with severe vision loss.

article

UK at the forefront of advanced therapies

26 August 2021 | By Ceri Roberts (NHS Blood and Transplant), Rachel Bell (Marks & Clerk)

Advanced therapies are a ground-breaking new class of medicines that use gene therapy, cell therapy or tissue engineering to treat disease and injury. Rachel Bell, Trainee Patent Attorney at Marks & Clerk, and Ceri Roberts, Scientific Training Manager – Cellular and Molecular Therapies at NHS Blood and Transplant, discuss some…

article

New regulatory guidance could lead to UK biosimilar boom

29 June 2021 | By Mark Samuels (British Biosimilars Association [BBA]))

New guidance on the licensing of biosimilar products that reduces unnecessary clinical trials is expected to put the UK ahead of Europe and facilitate a boom in these essential life-saving medicines, creating greater patient access and saving the National Health Service (NHS) hundreds of millions of pounds. It could also…

article

How implantable systems and microparticle depot injections are meeting the needs of long-acting drug delivery

26 June 2020 | By Jite Okoh (LLS Health), Kimberly Zubris (LLS Health)

Implantable systems and microparticle depots are used in many areas of drug delivery to release medicines at a controlled rate within the body. The use of these long-acting dosage forms eliminates the need for frequent administrations via traditional routes of administration, which ensures patient compliance and results in improved outcomes.…